H

Humana

Sells Medicare health plans and runs senior clinics

Informatics Lead - Clinical Intelligence

Full-TimeDeadline 10/13/27
$117.6k - $161.7k/yr+ Bonus incentive plan
Mid, Senior
Bachelor's, Master's
Remote in USA
RemoteOccasional travel to Humana offices for training or meetings may be required.
Data & AnalyticsData Science, Data Analysis

About the job

Requirements
  • A Bachelor's degree and 7+ years of data analytics experience, or a Master's degree and 4+ years of experience.
  • At least 4 years of experience analyzing clinical intelligence solutions that impact patient care decisions.
  • At least 4 years of experience evaluating outcomes, performance, and validation of artificial intelligence and machine learning solutions.
  • Advanced experience using SQL and Python to analyze complex datasets.
  • Ability to apply clinical and public health research methodologies to assess opportunities, quantify value, and guide enterprise-scale business and product investments.
  • Significant experience with data analysis and engineering for analytics, model evaluation techniques, and using data to drive business outcomes and decisions.
  • Significant experience articulating and presenting findings and insights to senior leadership.
  • Ability to meet the home internet requirements: at least 25 Mbps download and 10 Mbps upload, and a dedicated workspace without ongoing interruptions to protect member protected health information.
Responsibilities
  • Conduct data discovery, feasibility analysis, and opportunity sizing for Clinical Intelligence initiatives, supporting prioritization decisions and value case development.
  • Design and implement evaluation schemes for production Clinical Intelligence products, owning measurement of impact, drift, and accuracy against benchmarks.
  • Serve as a subject matter expert for population health benchmarks, owning a unified perspective across internal partners and external research.
  • Establish success metrics and measure the impact of intelligence capabilities on care coordination, personalization, operational efficiency, and patient outcomes.
  • Partner with product, clinical, business, data, and technology stakeholders to identify high-value opportunities where connected patient intelligence can improve decisions, experiences, and outcomes.
  • Lead exploratory analyses that identify unmet clinical and operational needs, quantify business value, and inform product roadmaps.
  • Create measurement plans and value hypotheses for new Clinical Intelligence capabilities before development and pilot launch.
  • Collaborate with product, engineering, artificial intelligence/machine learning, compliance, and operations teams to translate opportunities into scalable solutions.
  • Occasionally travel to Humana offices for training or meetings.
Desired Qualifications
  • A Master's degree in Public Health or a similar healthcare field, with a deep understanding of Epidemiology and/or Population Health.
  • Experience with Databricks or other cloud-based data transformation tools.
  • Experience with artificial intelligence-driven capabilities related to patient data, insights, and decision support.
  • Experience working in Agile or test-and-learn environments.

About the company

Humana sells health insurance paid for by government programs, chiefly Medicare Advantage plans that private insurers run for Americans 65 and older in place of traditional Medicare. It ranks among the largest Medicare Advantage insurers in the country and also runs Medicaid plans for low-income families in several states. Its CenterWell business operates senior primary care clinics, a mail-order pharmacy and home health services, so many members get care from a company the insurer owns. Medicare and states pay Humana a set monthly amount per member, and it keeps the difference between those payments and members' medical costs. Humana was founded in 1961 as a nursing home company and is based in Louisville, Kentucky.

Company Size

10,001+

Company Stage

IPO

Headquarters

Louisville, Kentucky

Founded

1961

Get referred to Humana

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Enrollment is surging: in July 2026 Humana affirmed about 25% individual Medicare Advantage membership growth for 2026.
  • Owned clinics create clinical careers: CenterWell Senior Primary Care added 130,900 patients, up 27%, in early 2026.
  • Medicaid is widening: Illinois chose Humana in June 2026 to run Medicaid coverage statewide.

What critics are saying

  • Low quality scores cut Medicare bonuses: only 20% of Humana's members sat in 4-star or better plans for 2026.
  • The insurer is shrinking to save margins: about 600,000 Medicare Advantage members got plan-closure notices in October 2026.
  • Stock grants carry risk: in July 2026 Humana cut its 2026 GAAP earnings floor to $6.52 a share from $8.36.

What makes Humana unique

  • Military families are a second market: Humana runs the Pentagon's TRICARE health plan across 24 eastern states and Washington, DC.
  • Florida anchors the business: Humana's Medicare Advantage contracts there produced 14% of its 2025 revenue.
  • Medicaid is a quiet second insurer: Humana covers over 1.54 million low-income members across 11 states.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Health Insurance
  • Dental Insurance
  • Vision Insurance
  • Life Insurance
  • Disability Insurance
  • Unlimited Paid Time Off
  • Paid Vacation
  • Paid Parental Leave
  • Short-term Disability
  • Long-term Disability
  • 401(k) Retirement Plan
  • 401(k) Company Match

Growth & Insights and Company News

Headcount

6 month growth

6%

1 year growth

6%

2 year growth

6%
Yahoo Finance
Oct 9th, 2026
Humana soars 15% as 95% of Medicare members join four-star plans, beating analyst expectations

Humana shares surged 15% after the insurer announced 95% of its Medicare Advantage members will be in plans rated four stars or higher for 2027, up from just 20% a year ago. The result significantly exceeded J.P. Morgan analysts' expectations of 60% to 70%. Plans with four-star ratings or higher qualify for government bonus payments worth billions across the industry. The industry average for 2027 stands at roughly 71%. However, these ratings will determine bonus payments for 2028, not 2027. The improved ratings are particularly significant given Humana's thin margins. The company's EBIT margin has declined from 4.3% in 2023 to 2.3% on a last-twelve-months basis. Meanwhile, competitors moved in the opposite direction. UnitedHealth's four-star share is estimated to fall to approximately 67% from 81%, whilst CVS Health's drops to around 70% from 84%. CVS shares declined roughly 3%.

Yahoo Finance
Sep 13th, 2026
US health insurers rebound as medical costs stabilise, analysts predict 16% earnings growth through 2030

The health insurance industry may have recovered from high medical costs, with analysts predicting strong growth through 2030. Morningstar forecasts 16% annual earnings per share growth for major insurers, above the industry's typical low-double-digit target. Health insurers are improving profitability by raising rates to cover increased medical utilisation. UnitedHealth Group reported over $5 billion in second-quarter net income, with its medical care ratio falling to 86.7% from 89.4% year-over-year. The outlook also improved for pharmacy benefit management operations at companies like UnitedHealth, CVS Health, and Cigna. Despite increased regulatory scrutiny, the "big three" PBMs maintain strong competitive positions. Third-quarter earnings reports next month should provide further clarity on the industry's financial health.

PR Newswire
Sep 2nd, 2026
Thyme Care raises $125M at $2B+ valuation to expand oncology care model

Thyme Care, a Nashville-based oncology company, has closed a Series E funding round of more than $125 million at a valuation exceeding $2 billion. Morgan Health led the round, with participation from CVS Health Ventures, Humana, AlleyCorp, HealthQuest Capital, Foresite Capital, Concord Health Partners, Frist Cressey Ventures, Town Hall Ventures, and a16z Bio + Health. The company now serves over 10.5 million people across all 50 US states and manages more than $7 billion in oncology spend. Thyme Care reports it is profitable with positive free cash flow whilst delivering validated reductions of 5 to 10 per cent in total cost of care. Alongside the funding, Thyme Care is establishing Thyme Companies, a parent entity that will build a portfolio of independent oncology businesses addressing care barriers. Co-founder Robin Shah will serve as executive chairman of the new entity.

Associated Press
Aug 20th, 2026
Humana appoints Dr. Shantanu Nundy as chief medical officer to lead AI and digital care strategy

Humana has appointed Dr Shantanu Nundy as Chief Medical Officer, effective 31 August. Dr Nundy, a practicing physician and healthcare executive, will help shape the company's products, platforms, and use of AI whilst bringing clinical expertise to the enterprise. He most recently served as Executive Vice President of Care Delivery and Chief Health Officer at Accolade, a healthcare navigation company. Previously, he was Managing Director for Clinical Innovation at Evolent Health, driving value-based and digital care transformation across health systems. Dr Nundy will report to Jim Rechtin, Humana's President and CEO, and join the company's Enterprise Leadership Team. He continues to practice primary care and hospital medicine.

Yahoo Finance
Aug 19th, 2026
Humana beats Q2 revenue estimates with $40.87B as health insurers face regulatory scrutiny

Humana reported Q2 revenues of $40.87 billion, up 26.2% year on year, exceeding analysts' expectations by 0.6%. The health insurance provider also beat earnings per share estimates. Despite the relatively strong results, Humana's stock has fallen 2.7% since the earnings announcement and currently trades at $378.11. The health insurance sector as a whole showed resilience in Q2, with the 12 tracked providers beating revenue consensus estimates by 2.8% on average. However, share prices across the sector have declined an average of 5.8% since reporting. Humana derives over 80% of its revenue from federal government contracts and serves approximately 17 million members, with a strong focus on Medicare Advantage plans for seniors.